Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Perspective Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 105 | 1 | 127 | +23 |
| Shares | 38.7M | 3.49M | 49.1M | +13.9M (+39.6%) |
| Value | $384.9M | $34.8M | $654.9M | +$304.8M (+87.0%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (42)
Institutions that held Perspective Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (19)
Institutions that held Perspective Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| OrbiMed Advisors LLC | 492,670 | $4.91M |
| Millennium Management LLC | 246,558 | $2.46M |
| Point72 Asset Management, L.P. | 202,572 | $2.02M |
| WealthPLAN Partners, LLC | 169,963 | $1.69M |
| Superstring Capital Management LP | 87,638 | $873.8K |
| Winton Group Ltd | 84,363 | $841.1K |
| Qube Research & Technologies Ltd | 83,346 | $831.0K |
| ADAR1 Capital Management, LLC | 69,985 | $697.8K |
| Y-Intercept (Hong Kong) Ltd | 63,581 | $633.9K |
| Renaissance Technologies LLC | 61,660 | $614.8K |
| Alpine Global Management, LLC | 44,714 | $445.8K |
| EAM Investors, LLC | 32,631 | $325.3K |
| Voloridge Investment Management, LLC | 15,963 | $159.2K |
| Bridgeway Capital Management, LLC | 13,400 | $133.6K |
| Point72 (DIFC) Ltd | 11,842 | $118.1K |
| State of Wyoming | 572 | $5.71K |
| Lazard Asset Management LLC | 523 | $5.00K |
| Headlands Technologies LLC | 152 | $1.51K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 51 | $508 |
Not filed for Q3 2024 yet (1)
Institutions that held Perspective Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,485,946 | $34.8M |